EMJARD L 5/10MG TAB

EMJARD L 5/10MG combines linagliptin and empagliflozin to help manage type 2 diabetes. Linagliptin works by increasing insulin release when blood sugar is high, while empagliflozin helps your kidneys remove excess glucose through urine. Together, these active ingredients provide dual action for better blood sugar control. Take as directed by your healthcare provider. Suitable for adults with type 2 diabetes when diet and exercise alone are not sufficient. Always consult your doctor before starting any new medication.